Shaji S Kumar

388PUBLICATIONS
770CO-AUTHORS
Modelling and simulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (388)

|Aug 29, 2026
Subtype specific artificial intelligence modelling of cardiac amyloidosis using echocardiography and electrocardiography.

|Aug 25, 2026
Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma.

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Aug 24, 2026
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

|Jul 27, 2026
Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

|Jul 27, 2026
Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.

Pageof 65

Frequent Collaborators

127 joint publications

Angela Dispenzieri

114 joint publications

Morie Gertz

105 joint publications

Vincent S Rajkumar

102 joint publications

Nelson R Leung